# BTA vs Baclofen for Pelvic Myofascial Pain Syndrome

> **NCT05617118** · — · UNKNOWN · sponsor: **Saint Petersburg State University, Russia** · enrollment: 52 (estimated)

## Conditions studied

- Chronic Pain
- Chronic Pelvic Pain Syndrome
- Myofascial Pain Syndrome
- Myofascial Trigger Point Pain
- Pelvic Floor Disorders

## Interventions

- **DRUG:** Baclofen 10mg
- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT05617118
- **Lead sponsor:** Saint Petersburg State University, Russia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2023-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05617118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05617118, "BTA vs Baclofen for Pelvic Myofascial Pain Syndrome". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT05617118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*